182 related articles for article (PubMed ID: 10464009)
1. Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods.
Hoffman B; Cho SJ; Zheng W; Wyrick S; Nichols DE; Mailman RB; Tropsha A
J Med Chem; 1999 Aug; 42(17):3217-26. PubMed ID: 10464009
[TBL] [Abstract][Full Text] [Related]
2. Application of validated QSAR models of D1 dopaminergic antagonists for database mining.
Oloff S; Mailman RB; Tropsha A
J Med Chem; 2005 Nov; 48(23):7322-32. PubMed ID: 16279792
[TBL] [Abstract][Full Text] [Related]
3. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
Wang XS; Tang H; Golbraikh A; Tropsha A
J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
[TBL] [Abstract][Full Text] [Related]
5. Partial least squares modeling and genetic algorithm optimization in quantitative structure-activity relationships.
Hasegawa K; Funatsu K
SAR QSAR Environ Res; 2000; 11(3-4):189-209. PubMed ID: 10969871
[TBL] [Abstract][Full Text] [Related]
6. Modeling of p38 mitogen-activated protein kinase inhibitors using the Catalyst HypoGen and k-nearest neighbor QSAR methods.
Xiao Z; Varma S; Xiao YD; Tropsha A
J Mol Graph Model; 2004 Oct; 23(2):129-38. PubMed ID: 15363455
[TBL] [Abstract][Full Text] [Related]
7. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.
Cormanich RA; Goodarzi M; Freitas MP
Chem Biol Drug Des; 2009 Feb; 73(2):244-52. PubMed ID: 19207427
[TBL] [Abstract][Full Text] [Related]
8. Comparative molecular field analysis-based prediction of drug affinities at recombinant D1A dopamine receptors.
Brusniak MY; Pearlman RS; Neve KA; Wilcox RE
J Med Chem; 1996 Feb; 39(4):850-9. PubMed ID: 8632409
[TBL] [Abstract][Full Text] [Related]
9. Improved 3D-QSAR CoMFA of the dopamine transporter blockers with multiple conformations using the genetic algorithm.
Yuan H; Petukhov PA
Bioorg Med Chem Lett; 2006 Dec; 16(24):6267-72. PubMed ID: 17027270
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of ordinal CoMFA by ridge logistic partial least squares.
Ohgaru T; Shimizu R; Okamoto K; Kawashita N; Kawase M; Shirakuni Y; Nishikiori R; Takagi T
J Chem Inf Model; 2008 Apr; 48(4):910-7. PubMed ID: 18338844
[TBL] [Abstract][Full Text] [Related]
11. 3D-QSAR study of 20 (S)-camptothecin analogs.
Lu AJ; Zhang ZS; Zheng MY; Zou HJ; Luo XM; Jiang HL
Acta Pharmacol Sin; 2007 Feb; 28(2):307-14. PubMed ID: 17241535
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional quantitative structure-activity relationship study of nonsteroidal estrogen receptor ligands using the comparative molecular field analysis/cross-validated r2-guided region selection approach.
Sadler BR; Cho SJ; Ishaq KS; Chae K; Korach KS
J Med Chem; 1998 Jun; 41(13):2261-7. PubMed ID: 9632359
[TBL] [Abstract][Full Text] [Related]
13. Application of the modelling power approach to variable subset selection for GA-PLS QSAR models.
Sagrado S; Cronin MT
Anal Chim Acta; 2008 Feb; 609(2):169-74. PubMed ID: 18261511
[TBL] [Abstract][Full Text] [Related]
14. A comparison of methods for modeling quantitative structure-activity relationships.
Sutherland JJ; O'Brien LA; Weaver DF
J Med Chem; 2004 Oct; 47(22):5541-54. PubMed ID: 15481990
[TBL] [Abstract][Full Text] [Related]
15. kappa Nearest neighbors QSAR modeling as a variational problem: theory and applications.
Itskowitz P; Tropsha A
J Chem Inf Model; 2005; 45(3):777-85. PubMed ID: 15921467
[TBL] [Abstract][Full Text] [Related]
16. QSAR modeling using chirality descriptors derived from molecular topology.
Golbraikh A; Tropsha A
J Chem Inf Comput Sci; 2003; 43(1):144-54. PubMed ID: 12546547
[TBL] [Abstract][Full Text] [Related]
17. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
Akula N; Lecanu L; Greeson J; Papadopoulos V
Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234
[TBL] [Abstract][Full Text] [Related]
18. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
Zhang H; Li H; Ma Q
J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
[TBL] [Abstract][Full Text] [Related]
19. Ordinal classification using Comparative Molecular Field Analysis.
Ohgaru T; Shimizu R; Okamoto K; Kawase M; Shirakuni Y; Nishikiori R; Takagi T
J Chem Inf Model; 2008 Jan; 48(1):207-12. PubMed ID: 18161957
[TBL] [Abstract][Full Text] [Related]
20. LIV-3D-QSAR models for PGI2 receptor ligands using multiple conformations.
Azevedo Martins RC; Girão Albuquerque M; Bicca de Alencastro R
Eur J Med Chem; 2004 Apr; 39(4):359-67. PubMed ID: 15072844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
